ACUTE MYELOID LEUKEMIA IN REMISSION
Clinical trials for ACUTE MYELOID LEUKEMIA IN REMISSION explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA IN REMISSION trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA IN REMISSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New transplant method aims to stop deadly complication, reduce need for lifelong drugs
Disease control OngoingThis study is testing a modified stem cell transplant for adults and children with serious blood cancers or disorders. The goal is to treat the disease while reducing the risk of a dangerous complication called graft-versus-host disease (GvHD). Researchers are using a special mac…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Apr 04, 2026 03:36 UTC
-
Two-Drug combo aims to keep blood cancer at bay
Disease control OngoingThis study is testing whether a two-drug combination can help keep acute myeloid leukemia (AML) from returning in patients who have achieved remission. The trial involves 50 adults with AML who have responded to initial treatment but are not candidates for stem cell transplant. P…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 04, 2026 03:35 UTC
-
New radiation technique tested to prepare patients for Life-Saving stem cell transplants
Disease control TerminatedThis early-phase study is testing the safety and best dose of a targeted radiation treatment, given with two chemotherapy drugs, to prepare patients for a donor stem cell transplant. The goal is to better wipe out cancer cells in the bone marrow before receiving healthy donor cel…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Apr 04, 2026 03:35 UTC
-
New drug trial aims to keep blood cancers at bay after transplant
Disease control OngoingThis study is testing whether taking the drug ruxolitinib after a stem cell transplant can help prevent cancer from returning in older patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). The trial involves 64 participants aged 60-80 who have achieved rem…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Donor vaccine shields cancer patients from dangerous Post-Transplant virus
Prevention OngoingThis study is testing a new vaccine approach to prevent a common and dangerous viral infection called CMV in patients receiving a stem cell transplant for blood cancer. Researchers are vaccinating the healthy stem cell donors before the transplant, hoping the donor's boosted immu…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Prevention
Last updated Apr 03, 2026 14:41 UTC
-
Scientists hunt for early warning signs of Leukemia's return
Knowledge-focused OngoingThis study aims to learn if tracking tiny amounts of leftover leukemia cells in the blood can help doctors predict and understand relapse in patients with acute myeloid leukemia (AML) who have received a stem cell transplant. Researchers will follow 303 adult patients in remissio…
Matched conditions: ACUTE MYELOID LEUKEMIA IN REMISSION
Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:56 UTC